HCFC1 and steatosis: The hepatocyte-specific Hcfc1 knockout in Hcfc1hepKO/Y males models the development of terminal NASH characterized by increased steatosis, mitochondrial defects, increased inflammation and cell death, hepatocyte ballooning, fibrosis, progenitor cell activation, and metabolic dysfunction.